235 related articles for article (PubMed ID: 6406444)
41. Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus.
Menkes DB; Aghajanian GK; McCall RB
Life Sci; 1980 Jul; 27(1):45-55. PubMed ID: 6249992
[No Abstract] [Full Text] [Related]
42. [The trophic function of the brain monoaminergic system and its importance in pathology].
Gromova EA; Semenova TP; Chubakov AR
Vestn Akad Med Nauk SSSR; 1988; (11):19-26. PubMed ID: 2853498
[No Abstract] [Full Text] [Related]
43. A study of the sensitivity of rat brain alpha 2-adrenoceptors during chronic antidepressant treatments.
Sugrue MF
Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):90-6. PubMed ID: 6289141
[No Abstract] [Full Text] [Related]
44. Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behaviour in mice.
Muley MP; Joshi MA; Manekar MS
J Pharm Pharmacol; 1984 Mar; 36(3):208-10. PubMed ID: 6144762
[TBL] [Abstract][Full Text] [Related]
45. Modification by spychotropic drugs of the cyclic adenosine monophosphate response to norepinephrine in rat brain.
Palmer GC; Robison GA; Sulser F
Biochem Pharmacol; 1971 Jan; 20(1):236-9. PubMed ID: 4328273
[No Abstract] [Full Text] [Related]
46. [Central serotonin receptors].
Fillion G
Pathol Biol (Paris); 1985 Apr; 33(4):221-6. PubMed ID: 2861595
[No Abstract] [Full Text] [Related]
47. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression.
Sulser F; Janowsky AJ; Okada F; Manier DH; Mobley PL
Neuropharmacology; 1983 Mar; 22(3 Spec No):425-31. PubMed ID: 6304560
[No Abstract] [Full Text] [Related]
48. Pharmacological profile and mechanism of action of antidepressant drugs.
Maj J
Acta Physiol Pol; 1987; 38(4):289-301. PubMed ID: 2898869
[No Abstract] [Full Text] [Related]
49. [Brain structures related to the mechanisms of depression and the mechanisms of action of antidepressive drugs].
Kostowski W; Płaźnik A
Psychiatr Pol; 1987; 21(4):317-25. PubMed ID: 3327071
[No Abstract] [Full Text] [Related]
50. Biochemical basis of analgesia: metabolism, storage, regulation, and action.
Greenberg S; Palmer GC
Dent Clin North Am; 1978 Jan; 22(1):31-46. PubMed ID: 23327
[No Abstract] [Full Text] [Related]
51. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
Cooper BR; Hester TJ; Maxwell RA
J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
[TBL] [Abstract][Full Text] [Related]
52. [New discoveries on antidepressive treatment: serotonin is the key].
Evenden J
Lakartidningen; 1997 Sep; 94(38):3262-6. PubMed ID: 9379793
[No Abstract] [Full Text] [Related]
53. On the relation between central noradrenaline and serotonin nerve terminals and postsynaptic receptors during ontogeny.
Jonsson G
Acta Physiol Scand Suppl; 1977; 452():23-6. PubMed ID: 273371
[No Abstract] [Full Text] [Related]
54. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD
J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970
[TBL] [Abstract][Full Text] [Related]
55. Effects of a new oxazolidinone derivative AS-8 on serotonin metabolism in the brains of mouse, rat and chick.
Chilmonczyk Z
Pol J Pharmacol; 1995; 47(5):445-9. PubMed ID: 8868138
[TBL] [Abstract][Full Text] [Related]
56. Effects of oestrogen and progesterone on brain monoamines: interactions with psychotropic drugs.
Greengrass PM; Tonge SR
J Pharm Pharmacol; 1972 Dec; 24():Suppl:149P. PubMed ID: 4144873
[No Abstract] [Full Text] [Related]
57. [Noradrenergic and serotoninergic brain structures and the auditory analyzer].
Khanbabian MV; Davtian MM
Usp Fiziol Nauk; 1988; 19(1):118-24. PubMed ID: 2834889
[No Abstract] [Full Text] [Related]
58. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
59. Shifting depression.
Campbell IC; Marsden K; Powell JF
Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
[No Abstract] [Full Text] [Related]
60. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
